Down-regulation of Dicer and Ago2 is associated with cell proliferation and apoptosis in prostate cancer

Tumor Biology

Volumn 35, Issue 11, 2014, Pages 11571-11578

  Bian, Xiao Jie ^a,b   Zhang, Gui Ming ^a,b   Gu, Cheng Yuan ^a,b   Cai, Ying ^a   Wang, Chao Fu ^a   Shen, Yi Jun ^a   Zhu, Yao ^a   Zhang, Hai Liang ^a   Dai, Bo ^a   Ye, Ding Wei ^a  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Ago2; Dicer; Prostate cancer; RNA interference

Indexed keywords

ARGONAUTE PROTEIN; DEAD BOX PROTEIN; DICER1 PROTEIN, HUMAN; EIF2C2 PROTEIN, HUMAN; RIBONUCLEASE III; SMALL INTERFERING RNA; TUMOR MARKER;

ANTAGONISTS AND INHIBITORS; APOPTOSIS; CANCER GRADING; CANCER STAGING; CELL CYCLE; CELL PROLIFERATION; ENZYME IMMUNOASSAY; GENETICS; HUMAN; MALE; METABOLISM; NEOPLASM; PATHOLOGY; PROGNOSIS; PROSTATE TUMOR; TUMOR CELL CULTURE; WESTERN BLOTTING;

APOPTOSIS; ARGONAUTE PROTEINS; BLOTTING, WESTERN; CELL CYCLE; CELL PROLIFERATION; DEAD-BOX RNA HELICASES; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; NEOPLASM GRADING; NEOPLASM STAGING; NEOPLASMS, HORMONE-DEPENDENT; PROGNOSIS; PROSTATIC NEOPLASMS; RIBONUCLEASE III; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84927798004     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13277-014-2462-3     Document Type: Article

References (27)

1. Center MM, Jemal A, Lortet-Tieulent J, Ward E, Ferlay J, Brawley O, et al. International variation in prostate cancer incidence and mortality rates. Eur Urol. 2012;61:1079–92.
2. Sakurai K, Amarzguioui M, Kim D-H, Alluin J, Heale B, Song M-s, et al. A role for human dicer in pre-RISC loading of siRNAs. Nucleic acids research. 2011;39:1510–25.
3. Kala R, Peek G, Hardy T, Tollefsbol T. MicroRNAs: an emerging science in cancer epigenetics. Journal of Clinical Bioinformatics. 2013;3:6.
4. Peters L, Meister G. Argonaute proteins: mediators of RNA silencing. Molecular Cell. 2007;26:611–23.
5. Kim VN, Han J, Siomi MC. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol. 2009;10:126–39.
6. Papachristou D, Korpetinou A, Giannopoulou E, Antonacopoulou A, Papadaki H, Grivas P, et al. Expression of the ribonucleases Drosha, Dicer, and Ago2 in colorectal carcinomas. Virchows Archiv: an international journal of pathology. 2011;459:431–40.
7. Papachristou D, Sklirou E, Corradi D, Grassani C, Kontogeorgakos V, Rao U. Immunohistochemical analysis of the endoribonucleases Drosha, Dicer and Ago2 in smooth muscle tumours of soft tissues. Histopathology. 2012;60:36.
8. Faggad A, Kasajima A, Weichert W, Stenzinger A, Elwali N. Dietel M, et al. Histopathology: Down-regulation of the microRNA processing enzyme Dicer is a prognostic factor in human colorectal cancer; 2012.
9. Khoshnaw S, Rakha E, Abdel-Fatah T, Nolan C, Hodi Z, Macmillan D, et al. Loss of Dicer expression is associated with breast cancer progression and recurrence. Breast Cancer Research and Treatment. 2012;135:403–13.
10. Zhang B, Chen H, Zhang L, Dakhova O, Zhang Y, Lewis MT, et al. A dosage-dependent pleiotropic role of Dicer in prostate cancer growth and metastasis. Oncogene. 2014;33:3099–108.
11. Zhang X, Graves P, Zeng Y. Overexpression of human argonaute2 inhibits cell and tumor growth. Biochimica et Biophysica Acta. 1830;2012:2553–61.
12. Shi TY, Yang G, Tu XY, Yang JM, Qian J, Wu XH, et al. Rad52 variants predict platinum resistance and prognosis of cervical cancer. PLoS One. 2012;7:e50461.
13. Chiosea S, Jelezcova E, Chandran U, Acquafondata M, McHale T, Sobol R, et al. Up-regulation of Dicer, a component of the microRNA machinery, in prostate adenocarcinoma. The American Journal of Pathology. 2006;169:1812–20.
14. Yoo N, Hur S, Kim M, Lee J, Lee S. Immunohistochemical analysis of RNA-induced silencing complex-related proteins ago2 and tnrc6a in prostate and esophageal cancers. APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica. 2010;118:271–6.
15. Boyd L, Mao X, Lu Y-J. The complexity of prostate cancer: genomic alterations and heterogeneity. Nature Reviews Urology. 2012;9:652–64.
16. Gregory RI, Shiekhattar R. MicroRNA biogenesis and cancer. Cancer Res. 2005;65:3509–12.
17. Croce CM, Calin GA. MiRNAs, cancer, and stem cell division. Cell. 2005;122:6–7.
18. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006;103:2257–61.
19. Oh YK, Park TG. SiRNA delivery systems for cancer treatment. Adv Drug Deliv Rev. 2009;61:850–62.
20. Han L, Zhang A, Zhou X, Xu P, Wang G-X, Pu P-Y, et al. Downregulation of Dicer enhances tumor cell proliferation and invasion. International Journal of Oncology. 2010;37:299–305.
21. Bai Y, Qiu G-R, Zhou F, Gong L-Y, Gao F, Sun K-L. Overexpression of Dicer1 induced by the upregulation of gata1 contributes to the proliferation and apoptosis of leukemia cells. International Journal of Oncology. 2013;42:1317–24.
22. Naoghare P, Tak Y, Kim M, Han E, Song J. Knock-down of argonaute 2 (ago2) induces apoptosis in myeloid leukaemia cells and inhibits siRNA-mediated silencing of transfected oncogenes in hek-293 cells. Basic & Clinical Pharmacology & Toxicology. 2011;109:274–82.
23. Asai T, Suzuki Y, Matsushita S, Yonezawa S, Yokota J, Katanasaka Y, et al. Disappearance of the angiogenic potential of endothelial cells caused by argonaute2 knockdown. Biochemical and Biophysical Research Communications. 2008;368:243–8.
24. McLoughlin H, Fineberg S, Ghosh L, Tecedor L, Davidson B. Dicer is required for proliferation, viability, migration and differentiation in corticoneurogenesis. Neuroscience. 2012;223:285–95.
25. Narayanan R, Jiang J, Gusev Y, Jones A, Kearbey J, Miller D, et al. MicroRNAs are mediators of androgen action in prostate and muscle. PloS One. 2010. doi:10.1371/journal.pone.0013637.
26. Carthew R, Sontheimer E. Origins and mechanisms of miRNAs and siRNAs. Cell. 2009;136:642–55.
27. Koscianska E, Starega-Roslan J, Krzyzosiak W. The role of Dicer protein partners in the processing of microRNA precursors. PloS one 2011;6